![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 12")
Policy Watch: 20 Regulatory Updates — March 20, 2026
Policy WatchMarch 20, 2026. 20 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
Policy Watch: 10 Regulatory Updates — March 18, 2026
Policy WatchMarch 18, 2026. 10 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
Policy Watch: 27 Regulatory Updates — March 16, 2026
Policy WatchMarch 16, 2026. 27 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
AM Policy Update: March 16, 2026
AM Policy UpdateMarch 16, 2026. 20 regulatory items from Federal Register, regulations.gov, and regulatory RSS feeds. Score 85Federal RegisterSchedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule IThe DEA temporarily placed…
Policy Watch: 25 Regulatory Updates — March 12, 2026
Policy WatchMarch 12, 2026. 25 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.govSchedules of…